. Author manuscript; available in PMC: 2019 Mar 7.

Published in final edited form as: Ann Surg Oncol. 2013 May 17;20(9):3106–3111. doi: 10.1245/s10434-013-2999-1

TABLE 3.

Indications for surgery stratified by site of disease

Metastasectomy site	n (%)	Isolated disease	Progressive disease	Symptomatic disease
Subcutaneous	12 (35 %)	2	5	5
Intra-abdominal^a	11 (32 %)	0	7	4
Brain	5 (15 %)	0	0	5
Nodal	3 (9 %)	1	2	0
Other^b	3 (9 %)	0	0	3

Five of these cases involved a bowel resection and anastomosis

One patient had surgery as a result of ipilimumab toxicity